Rafina Innovations Inc. (VICA) Research

Rafina Innovations Inc. is a company that develops, researches, commercializes, and markets medical technologies. Its operations are divided into two main areas: its Clinic division and its Technology division. The company manages specialized rehabilitation clinics for prosthetics, orthotics, and comprehensive diabetic foot care, serving patients in Southern Europe, the Middle East, and North Africa. Within its Technology arm, Rafina Innovations Inc. is actively engaged in the creation, development, and market introduction of medical devices, innovative methods, and products. This work covers a broad range of fields, including but not limited to, prosthetics, orthotics, general rehabilitation, bioengineering, mobility, diabetes and diabetic foot care, tissue mechanics, ultrasonics, medical signal processing and analysis, general medical technology, orthopedics, and robotic surgery. Additionally, the company licenses its proprietary technological advancements. Founded in 2007, the company changed its name from HCi Viocare to Rafina Innovations Inc. in July 2018. Its base of operations is in Glasgow, United Kingdom.

Market snapshot

Symbol
VICA
Price
$0.00
Day change
0.00%
Market cap
$14.6K
P/E ratio
-0.09x
52-week range
0.0001-0.0012
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Baudax Bio, Inc. (BXRXQ)
  • Cyclo3pss Corporation (CYPS)
  • Emergent Health Corp (EMGE)
  • Innovation1 Biotech Inc. (IVBT)
  • Kaleido Biosciences, Inc. (KLDO)
  • Caliber Imaging & Diagnostics, Inc. (LCDX)
  • Nemaura Medical Inc. (NMRD)
  • Remedent, Inc. (REMI)

Recent insider activity

  • Zertalis Constantinos — P-Purchase (3000 shares) on 2018-07-20
  • Zertalis Constantinos — P-Purchase (700 shares) on 2018-07-13
  • Zertalis Constantinos — P-Purchase (500 shares) on 2018-06-28
  • Zertalis Constantinos — P-Purchase (173363 shares) on 2018-06-28
  • Zertalis Constantinos — P-Purchase (500 shares) on 2018-06-27

Open Rafina Innovations Inc. (VICA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.